Modification of butylated hydroxytoluene-induced pulmonary toxicity in mice by diethyl maleate, buthionine sulfoximine, and cysteine.
Treatment of mice with diethyl maleate (DEM) or buthionine sulfoximine (BSO) significantly enhanced the lung injury caused by butylated hydroxytoluene (BHT). Conversely, cysteine protected mice from the lung toxicity of BHT. BHT administration to mice produced a time-dependent reduction of glutathione (GSH) content in the lung, but not in the liver. These results support the concept that conjugation of 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (BHT-quinone methide), a proposed reactive metabolite of BHT, with GSH is involved in the detoxification of BHT in mice.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D019328:Buthionine Sulfoximine; D002084:Butylated Hydroxytoluene / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000633:toxicity*; D003545:Cysteine / Q000494:pharmacology*; D004357:Drug Synergism; D005978:Glutathione / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008298:Maleates / Q000633:toxicity*; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives* / Q000633:toxicity; D051379:Mice; D009929:Organ Size / Q000187:drug effects
D008298:Maleates; D008717:Methionine Sulfoximine; D002084:Butylated Hydroxytoluene; D019328:Buthionine Sulfoximine; C014476:diethyl maleate; D005978:Glutathione; D003545:Cysteine